Blueshift Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$983K Buy
+40,820
New +$1.07M 0.23% 72
2026
Q1
Sell
-50,449
Closed -$1.26M 615
2025
Q4
$1.26M Buy
+50,449
New +$1.27M 0.36% 58
2024
Q4
Sell
-48,001
Closed -$1.39M 480
2024
Q3
$1.39M Buy
48,001
+16,235
+51% +$474K 0.34% 59
2024
Q2
$889K Buy
+31,766
New +$875K 0.3% 83
2022
Q4
Sell
-5,993
Closed -$262K 561
2022
Q3
$262K Sell
5,993
-896
-13% -$43.5K 0.06% 438
2022
Q2
$361K Buy
6,889
+2,560
+59% +$130K 0.06% 396
2022
Q1
$224K Sell
4,329
-20,198
-82% -$1.05M 0.02% 705
2021
Q4
$1.45M Sell
24,527
-13,589
-36% -$673K 0.13% 221
2021
Q3
$1.64M Buy
38,116
+15,733
+70% +$697K 0.09% 282
2021
Q2
$877K Buy
22,383
+5,831
+35% +$227K 0.05% 390
2021
Q1
$600K Sell
16,552
-176,105
-91% -$6.25M 0.06% 423
2020
Q4
$7.09M Buy
+192,657
New +$7.07M 0.84% 7
2020
Q3
Sell
-131,636
Closed -$4.08M 734
2020
Q2
$4.08M Buy
131,636
+101,577
+338% +$3.45M 0.66% 24
2020
Q1
$931K Buy
+30,059
New +$1.02M 0.87% 32
2019
Q4
Sell
-101,920
Closed -$3.47M 982
2019
Q3
$3.47M Buy
+101,920
New +$3.71M 0.53% 31
2019
Q1
Sell
-77,252
Closed -$3.2M 880
2018
Q4
$3.2M Buy
+77,252
New +$3.21M 0.59% 12

Other funds holding PFE

Blueshift Asset Management's PFE Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 40,820 shares worth $983K. The stake represents 0.23% of the portfolio and ranks #72 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in PFE as recently as Q4 2025.

Blueshift Asset Management first reported a position in PFE in Q4 2018 and has held it in 16 quarters since. The position peaked at $7.09M in Q4 2020. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Blueshift Asset Management held 40,820 shares of Pfizer worth $983K as of Q2 2026.
  • Pfizer was a new Blueshift Asset Management position in Q2 2026.
  • Pfizer made up 0.23% of Blueshift Asset Management's portfolio in Q2 2026, its #72 holding.
  • Blueshift Asset Management first reported a position in Pfizer in Q4 2018 and has held it in 16 quarters since.
  • Blueshift Asset Management's Pfizer position peaked at $7.09M in Q4 2020.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.